Access cutting-edge parkinson's disease treatment through this clinical trial at a research site in Georgetown. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Georgetown location
Preparing your pre-screening questions…
Access parkinson's disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related parkinson's disease treatment provided free
Check if you qualify for this parkinson's disease clinical trial in Georgetown, TX
No-Cost Study Care
Local to Georgetown
Convenient for TX residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement. This study will assess how effective Foslevodopa/Foscarbidopa is in treating adult participants earlier within advanced Parkinson disease under routine clinical practice. Foslevodopa/Foscarbidopa is an approved drug for the treatment of Parkinson's Disease. Approximately 100 adult participants who are prescribed Foslevodopa/Foscarbidopa by their doctors will be enrolled across approximately 40 sites across the world. Participants will receive Foslevodopa/Foscarbidopa subcutaneous infusion as prescribed by their physician. Participants will be followed for up to 6 months. There are no additional examinations due to the study but the participants and caregivers will need to fill several questionnaires to generate data on their motor function and well-being
Sponsor: AbbVie
Yes, this clinical trial (NCT07227896) has an active research site in Georgetown, TX that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for parkinson's disease treatment options in Georgetown, TX, this clinical trial (NCT07227896) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Georgetown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced parkinson's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all parkinson's disease clinical trials near you to find additional studies recruiting in your area.
See all parkinsons disease clinical trials recruiting in Georgetown — not just this study.
Browse Parkinsons Disease Trials in Georgetown →